These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6542007)

  • 1. Tumour regression after extracorporeal affinity chromatography of blood plasma across agarose beads containing staphylococcal protein A.
    Håkansson L; Jonsson S; Söderberg M; Eneström S; Liedén G; Lindgren S
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1377-88. PubMed ID: 6542007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous large multivalent immunogen vaccine in patients with metastatic melanoma and renal cell carcinoma.
    Dudek AZ; Mescher MF; Okazaki I; Math VT; Luo X; Curtsinger JM; Miller JS
    Am J Clin Oncol; 2008 Apr; 31(2):173-81. PubMed ID: 18391603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of extracorporeal on-line large-scale plasma adsorptions on protein A-sepharose columns in cancer patients.
    Wallmark A; Grubb A; Freiburghaus C; Flodgren P; Husberg B; Lindholm T; Lindström C; Thysell H; Sjögren HO
    Artif Organs; 1984 Feb; 8(1):72-81. PubMed ID: 6367720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hematologic toxicity of interleukin-2 in patients with metastatic melanoma and renal cell carcinoma.
    MacFarlane MP; Yang JC; Guleria AS; White RL; Seipp CA; Einhorn JH; White DE; Rosenberg SA
    Cancer; 1995 Feb; 75(4):1030-7. PubMed ID: 7842405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged survival in a patient with multiple metachronous tumors.
    Sherriff JM; Walji N
    J Clin Oncol; 2011 Mar; 29(7):e154-5. PubMed ID: 21149650
    [No Abstract]   [Full Text] [Related]  

  • 6. Metastatic malignant melanoma: regression induced by combined treatment with interferon [HuIFN-alpha(Le)] and cimetidine.
    Flodgren P; Borgström S; Jönsson PE; Lindström C; Sjögren HO
    Int J Cancer; 1983 Dec; 32(6):657-65. PubMed ID: 6654521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experiences in immunotherapy of cancer.
    Krementz ET; Samuels MS; Wallace JH; Benes EN
    Surg Gynecol Obstet; 1971 Aug; 133(2):209-17. PubMed ID: 5284416
    [No Abstract]   [Full Text] [Related]  

  • 8. Pilot studies using melanoma tumor-associated antigens (TAA) in specific-active immunochemotherapy of malignant melanoma.
    Hollinshead A; Arlen M; Yonemoto R; Cohen M; Tanner K; Kundin WD; Scherrer J
    Cancer; 1982 Apr; 49(7):1387-404. PubMed ID: 7059953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.
    Hidalgo OF; Aramendía JM; Alonso G; Foncillas JG; Brugarolas A
    Rev Med Univ Navarra; 1996; 40(3):6-12. PubMed ID: 9499820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case of renal metastasis of melanoma successfully controlled by a combination therapy of nivolumab and radiation.
    Kasuya A; Fukuchi K; Sano Y; Tatsuno K; Kitano S; Ishibe J; Fujiyama T; Tokura Y
    J Dermatol; 2018 Sep; 45(9):e246-e247. PubMed ID: 29574914
    [No Abstract]   [Full Text] [Related]  

  • 11. Malignant melanoma with metastasis to adenocarcinoma of the prostate.
    Grignon DJ; Ro JY; Ayala AG
    Cancer; 1989 Jan; 63(1):196-8. PubMed ID: 2910417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.
    Lieberman R; Wybran J; Epstein W
    Cancer; 1975 Mar; 35(3):756-77. PubMed ID: 234295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic melanoma of the tonsil.
    Sood S; Nair SB; Fenwick JD; Horgan K
    J Laryngol Otol; 1999 Nov; 113(11):1036-8. PubMed ID: 10696391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.
    Rosenberg SA; White DE
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):81-4. PubMed ID: 8859727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abscopal effect in the treatment of malignant melanoma].
    Thallinger C; Prager G; Ringl H; Zielinski C
    Hautarzt; 2015 Jul; 66(7):545-8. PubMed ID: 25576145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of renal cell carcinoma and melanoma patients with immune RNA.
    Pilch YH
    J Exp Pathol; 1987; 3(4):501-14. PubMed ID: 2457665
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidermotropic metastatic malignant melanoma.
    Mehregan DA; Bergeon MT; Mehregan DR
    Cutis; 1995 Apr; 55(4):225-7. PubMed ID: 7796615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor responses after reinfusion of autologous plasma perfused over immobilized protein A: a study in patients at advanced stages of cancer].
    Yamamoto T; Okada T; Seshimo T; Abe M; Yano S; Tarumi T; Naitoh A; Tamura K; Nakase A
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):13-24. PubMed ID: 2324585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous metastatic malignant melanoma and primary adenocarcinoma in the colon.
    Chiu HH; Liu YW; Huang CC
    Gastrointest Endosc; 2007 Sep; 66(3):600; discussion 601. PubMed ID: 17681502
    [No Abstract]   [Full Text] [Related]  

  • 20. [Regression of over 150 skin metastases of malignant melanoma with complex homeopathic therapy].
    Ehring F
    Hautarzt; 1989 Jan; 40(1):23-7. PubMed ID: 2921115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.